drugset / Trial / NCT03858725
Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-374 5 mg in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
This study is a randomized, open-label, fasted, single dose, crossover study to evaluate the pharmacokinetic profiles and safety of CKD-374 5 mg in healthy volunteers.
Timeline
- Start
- 2019-02-26
- Primary completion
- 2019-04-05
- Completion
- 2019-05-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | D569 | Unknown | — | Oral |
| Subject | Tofacitinib | Small molecule | 5 mg | Oral |